Lebwohl, M., A. Blauvelt, A. Menter, K. Papp, and A. Jacobson. “Long-Term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S26, doi:10.25251/skin.3.supp.26.